Tianjin Ringpu Bio Tech Financial Flexibility Index
Tianjin Ringpu Bio Tech financial flexibility index. Tianjin Ringpu Bio Tech (300119) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥128.27 Million (operating CF CN¥105.02 Million minus capex CN¥23.24 Million) represents 0% of total liabilities (CN¥2.54 Billion). See 300119 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tianjin Ringpu Bio Tech (2007–2025)
Financial flexibility index of Tianjin Ringpu Bio Tech from 2007 to 2025. Historical Financial Flexibility Index trend for Tianjin Ringpu Bio Tech across 19 annual periods. Check Tianjin Ringpu Bio Tech (300119) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Tianjin Ringpu Bio Tech Financial Flexibility Index by Year (2007–2025)
Tianjin Ringpu Bio Tech financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Tianjin Ringpu Bio Tech. For the full cash flow conversion analysis, see cash flow conversion of Tianjin Ringpu Bio Tech.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥473.64 Million | CN¥297.53 Million | CN¥2.47 Billion | ▼ -38.4% |
| 2024 | 0.31x | CN¥920.88 Million | CN¥735.55 Million | CN¥2.96 Billion | ▼ -10.5% |
| 2023 | 0.35x | CN¥622.68 Million | CN¥378.20 Million | CN¥1.79 Billion | ▼ -26.8% |
| 2022 | 0.47x | CN¥761.92 Million | CN¥389.49 Million | CN¥1.61 Billion | ▼ -5.7% |
| 2021 | 0.50x | CN¥688.50 Million | CN¥382.63 Million | CN¥1.37 Billion | ▼ -9.6% |
| 2020 | 0.56x | CN¥647.61 Million | CN¥388.44 Million | CN¥1.16 Billion | ▲ +9.6% |
| 2019 | 0.51x | CN¥613.31 Million | CN¥383.61 Million | CN¥1.21 Billion | ▲ +31.7% |
| 2018 | 0.39x | CN¥287.33 Million | CN¥174.88 Million | CN¥744.03 Million | ▲ +33.5% |
| 2017 | 0.29x | CN¥216.44 Million | CN¥107.57 Million | CN¥747.95 Million | ▼ -45.9% |
| 2016 | 0.53x | CN¥335.80 Million | CN¥207.67 Million | CN¥627.74 Million | ▼ -17.6% |
| 2015 | 0.65x | CN¥376.36 Million | CN¥225.27 Million | CN¥579.77 Million | ▼ -46.4% |
| 2014 | 1.21x | CN¥311.48 Million | CN¥128.37 Million | CN¥257.23 Million | ▲ +0.7% |
| 2013 | 1.20x | CN¥340.29 Million | CN¥88.68 Million | CN¥282.89 Million | ▼ -3.2% |
| 2012 | 1.24x | CN¥257.29 Million | CN¥89.92 Million | CN¥206.99 Million | ▼ -20.9% |
| 2011 | 1.57x | CN¥275.10 Million | CN¥90.29 Million | CN¥175.12 Million | ▲ +91.4% |
| 2010 | 0.82x | CN¥160.61 Million | CN¥112.82 Million | CN¥195.66 Million | ▲ +39.2% |
| 2009 | 0.59x | CN¥95.93 Million | CN¥64.59 Million | CN¥162.63 Million | ▼ -42.7% |
| 2008 | 1.03x | CN¥87.73 Million | CN¥68.07 Million | CN¥85.18 Million | ▲ +43.2% |
| 2007 | 0.72x | CN¥36.14 Million | CN¥19.15 Million | CN¥50.26 Million | — |